TotalMarketCap

ARS Pharmaceuticals

SPRYNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$263.038 M

$2.65 -13.28%

Close of 6 Nov 2026

As of 6 Nov 2026, ARS Pharmaceuticals (SPRY) has a market capitalization of $263.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$84.3M

#2543 by revenue

Earnings

-$171.3M

Loss-making

Shares outstanding

100,528,400

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #227Cypherpunk TechnologiesCYPH$265.6M
  2. #228Q32 BioQTTB$265.1M
  3. #229ARS PharmaceuticalsSPRY$263.0M
  4. #230EvommuneEVMN$262.8M
  5. #231BioAge LabsBIOA$254.3M

What if ARS Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$283,937.94

Per share 107,349× higher

Bitcoin $1.53T

$15,363.39

Per share 5,808× higher

Apple $5.02T

$50,436.57

Per share 19,069× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for ARS Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.